Pasithea Therapeutics
(NASDAQ) KTTA
Pasithea Therapeutics Financials at a Glance
Market Cap
$17.13M
Revenue (TTM)
$0.00
Net Income (TTM)
$20.43B
EPS (TTM)
$-3.57
P/E Ratio
-0.21
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.72
Volume
52,603
Open
$0.69
Price
$0.72
Volume
52,603
Open
$0.69
Previous Close
$0.72
Daily Range
$0.60 - $0.73
52-Week Range
$0.28 - $3.79
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.72
Volume
52,603
Open
$0.69
Previous Close
$0.72
Daily Range
$0.60 - $0.73
52-Week Range
$0.28 - $3.79
KTTA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pasithea Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Tiago Reis Marques, MD, PhD
Website
www.pasithea.comHeadquarters
Miami Beach, FL 33139, US
KTTA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-58%
Return on Capital
-38%
Return on Assets
-34%
Earnings Yield
-4.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$17.13M
Shares Outstanding
23.09M
Volume
52.60K
Short Interest
0.00%
Avg. Volume
160.02K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$20.86B
EBITDA
$20.86B
Operating Cash Flow
$15.21B
Capital Expenditure
$0.00
Free Cash Flow
$15.21B
Cash & ST Invst.
$55.16B
Total Debt
$0.00
Pasithea Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$181.54K
+211.9%
Gross Margin
0.00%
N/A
Market Cap
$17.13M
N/A
Market Cap/Employee
$4.28M
N/A
Employees
4
N/A
Net Income
$20.42B
-642428.1%
EBITDA
$20.85B
-691259.4%
Quarterly Fundamentals
Net Cash
$55.16B
+796680.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-33.91%
N/A
Return on Invested Capital
-37.74%
N/A
Free Cash Flow
$1.53B
-62600.8%
Operating Cash Flow
$1.53B
-62600.9%